caplacizumab

Italy

Drugs containing this active substance

  • CABLIVI

    It is used to treat an episode of acquired thrombotic thrombocytopenic purpura in adults and adolescents aged 12 years and older weighing at least 40 kg. This medicine prevents the formation of blood clots in small blood vessels.

    Form: solution for injection, powder and solvent

    Active substance Dosage
    caplacizumab -

    ATC: B01AX07

    Manufacturer: ABLYNX N.V.